The role of targeted BRCA1 / BRCA2 mutation analysis in hereditary breast/ovarian cancer families of Portuguese ancestry
β Scribed by Peixoto, A.; Santos, C.; Pinto, P.; Pinheiro, M.; Rocha, P.; Pinto, C.; Bizarro, S.; Veiga, I.; Principe, A.S.; Maia, S.; Castro, F.; Couto, R.; Gouveia, A.; Teixeira, M.R.
- Book ID
- 124078900
- Publisher
- John Wiley and Sons
- Year
- 2014
- Tongue
- English
- Weight
- 743 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0009-9163
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sixty high-risk breast and/or ovarian cancer families from North-Eastern Poland were screened for germline mutations in BRCA1 (MIM# 113705) and BRCA2 (MIM# 600185), using a combination of protein truncation test, denaturing high-performance liquid chromatography and direct sequencing. Sixteen (27%)
Germline mutations in the BRCA1 and BRCA2 genes are responsible for the predisposition and development of familial breast and/or ovarian cancer. Most mutations of BRCA1 and BRCA2 associated with breast and/or ovarian cancer result in truncated proteins. To investigate the presence of BRCA1 and BRCA2
Ethnic differences in cancer incidence and mortality result from differences in genetic and epidemiologic risk factors. Mutations in BRCA1 and BRCA2 account for a small proportion of all breast cancer cases, but for a much higher proportion of cases with a strong family history of breast or ovarian